Schobel Alexander Mark
Officer at AQST
- Sold, on record
- $1.6M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Mar 15, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AQSTAquestive Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AQSTPlan not statedApr 29, 2020 2020
Sold 40,000 shares at $4.50 ($180k)
Schobel Alexander Mark, Chief Innovation/Tech Officer
Sold 3.8% of holdings ($4.8M position)1M shares leftFirst sale on recordFiling
- 2 Form 4 sale AQSTPlan not statedMay 8, 2020 +9 days
Sold 40,000 shares at $5.00 ($200k)
Schobel Alexander Mark, Chief Innovation/Tech Officer
Sold 4.2% of holdings ($4.7M position)902,113 shares leftFiling
- 3 Form 4 sale AQSTPlan not statedFeb 8, 2021 +276 days
Sold 40,792 shares at $6.50 ($265k)
Schobel Alexander Mark, Chief Innovation/Tech Officer
Sold 4.5% of holdings ($5.9M position)872,000 shares left1x usual sizeFiling
- 4 Form 4 sale AQSTPlan not statedFeb 10, 2021 +2 days
Sold 35,000 shares at $6.75 ($236k)
Schobel Alexander Mark, Chief Innovation/Tech Officer
Sold 4% of holdings ($5.9M position)837,000 shares left0.9x usual sizeFiling
- 5 Form 144 notice AQSTNoticeMar 8, 2024 +1122 days
Filed to sell 25,000 shares ($140k)
Schobel Alexander Mark, Officer
10b5-1 planFirst sale on recordFiling
- 6 Form 4 sale AQSTRoutineMar 8, 2024 same day
Sold 25,000 shares at $5.19 ($130k)
Schobel Alexander Mark, Chief Innovation/Tech Officer
10b5-1 planSold 2.3% of holdings ($5.5M position)1M shares leftFirst sale on recordFollows a Form 144Filing
- 7 Form 144 notice AQSTNoticeMar 15, 2024 +7 days
Filed to sell 50,000 shares ($300k)
Schobel Alexander Mark, Officer
10b5-1 planFiling
- 8 Form 4 sale AQSTRoutineMar 15, 2024 same day
Sold 50,000 shares at $6.00 ($300k)
Schobel Alexander Mark, Chief Innovation/Tech Officer
10b5-1 planSold 4.8% of holdings ($6.2M position)984,476 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Mar 19, 2024 | AQST | Chief Innovation/Tech Officer | Form 4 sale | 50,000 | $300k | 4.8% | Routine | SEC |
| Mar 15, 2024 | Mar 15, 2024 | AQST | Officer | Form 144 notice | 50,000 | $300k | Notice | SEC | |
| Mar 8, 2024 | Mar 12, 2024 | AQST | Chief Innovation/Tech Officer | Form 4 sale | 25,000 | $130k | 2.3% | Routine | SEC |
| Mar 8, 2024 | Mar 8, 2024 | AQST | Officer | Form 144 notice | 25,000 | $140k | Notice | SEC | |
| Feb 10, 2021 | Feb 10, 2021 | AQST | Chief Innovation/Tech Officer | Form 4 sale | 35,000 | $236k | 4.0% | Plan not stated | SEC |
| Feb 8, 2021 | Feb 9, 2021 | AQST | Chief Innovation/Tech Officer | Form 4 sale | 40,792 | $265k | 4.5% | Plan not stated | SEC |
| May 8, 2020 | May 11, 2020 | AQST | Chief Innovation/Tech Officer | Form 4 sale | 40,000 | $200k | 4.2% | Plan not stated | SEC |
| Apr 29, 2020 | May 1, 2020 | AQST | Chief Innovation/Tech Officer | Form 4 sale | 40,000 | $180k | 3.8% | Plan not stated | SEC |
| Apr 27, 2020 | May 4, 2020 | AQST | Chief Innovation/Tech Officer | Form 4 sale | 80,000 | $308k | 7.8% | Plan not stated | SEC |